STXBP1 and neurodevelopmental disorder: Given that the prevalence of Munc18‐1 variants among individuals with unspecified developmental disorders is 0.25–0.5% and the prevalence of intellectual disability in the general population is 1%, the number of individuals diagnosed with Munc18‐1‐associated neurodevelopmental disorders will likely rise substantially (O'Brien et al, 2019).